Quarterly report pursuant to Section 13 or 15(d)

Stockholders' (Deficit) Equity - Addtional Information (Details)

v3.23.2
Stockholders' (Deficit) Equity - Addtional Information (Details)
 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 19, 2023
USD ($)
Jul. 18, 2023
Jun. 29, 2023
Apr. 19, 2023
USD ($)
$ / shares
shares
Jun. 30, 2023
shares
Jun. 30, 2022
shares
Jun. 30, 2023
USD ($)
shares
Jun. 30, 2022
shares
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]                  
Forward split ratio     0.25       0.25   0.25
Net proceeds from offering             $ 6,431,615    
Debt Seller | Maestro Health LLC                  
Subsidiary, Sale of Stock [Line Items]                  
Percentage of payment on net proceeds of offering until such time as purchase price paid in full       35.00%          
Payment on net proceeds of offering until such time as purchase price paid in full       $ 2,294,751          
Debt Seller | Maestro Health LLC | Subsequent Event                  
Subsidiary, Sale of Stock [Line Items]                  
Percentage of payment on net proceeds of offering due amount as purchase price to be paid   50.00%              
Payment on net proceeds of offering due amount as purchase price to be paid $ 1,147,376                
Common Stock [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Number of shares issued | shares         1,850,000   1,850,000    
Shares issued to vendors in exchange for services (in shares) | shares           5,625 25,000 5,625  
Public Offering                  
Subsidiary, Sale of Stock [Line Items]                  
Number of shares issued | shares       1,850,000          
Price per share | $ / shares       $ 4          
Gross proceeds from offering       $ 7,400,000          
Net proceeds from offering       $ 6,400,000